HH Linctus-LS Expectorant is a combination syrup formulated to provide effective relief from respiratory conditions characterized by productive cough and bronchial congestion. It contains Ambroxol hydrochloride (30mg/5ml), a mucolytic agent that facilitates the breakdown and clearance of mucus, thereby improving airway patency. Levosalbutamol (1mg/5ml), a selective β2-adrenergic receptor agonist, acts as a bronchodilator to relax bronchial smooth muscles, reducing bronchospasm and enhancing airflow. Guaifenesin (50mg/5ml), an expectorant, aids in thinning and loosening mucus in the airways, promoting easier expectoration. This synergistic combination addresses multiple pathophysiological aspects of respiratory ailments such as bronchitis, chronic obstructive pulmonary disease (COPD), and asthma exacerbations with mucus hypersecretion. HH Linctus-LS is indicated for symptomatic relief of cough associated with thick mucus and bronchospasm. The formulation is intended for oral administration, with dosing tailored according to patient age and severity of symptoms. Caution is advised in patients with hypersensitivity to any component, cardiovascular disorders, or hyperthyroidism. Use under medical supervision is recommended to ensure optimal therapeutic outcomes and monitor for potential adverse effects such as tachycardia, tremors, or gastrointestinal disturbances.